Dr. Kelly Davison
Claim this profileThe Research Institute of the McGill University
Studies Lymphoma
Studies Hodgkin's Lymphoma
4 reported clinical trials
10 drugs studied
Area of expertise
1Lymphoma
Stage IV
Stage III
MYC positive
2Hodgkin's Lymphoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Kelly Davison is currently running
Loncastuximab Tesirine + Rituximab
for Lymphoma
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemotherapy.
Recruiting2 awards Phase 3
Pembrolizumab + Brentuximab Vedotin
for Hodgkin's Lymphoma
This study is being done to determine if two new drugs can shrink or eliminate classical Hodgkins lymphoma.
Recruiting1 award Phase 2
More about Kelly Davison
Clinical Trial Related11 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kelly Davison has experience with
- Brentuximab Vedotin
- Pembrolizumab
- Brentuximab Vedotin
- Nivolumab
- Doxorubicin Hydrochloride
- Dacarbazine
Breakdown of trials Kelly Davison has run
Lymphoma
Hodgkin's Lymphoma
Peripheral T-Cell Lymphoma
T-Cell Lymphoma
Multiple Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kelly Davison specialize in?
Kelly Davison focuses on Lymphoma and Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Kelly Davison currently recruiting for clinical trials?
Yes, Kelly Davison is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Kelly Davison has studied deeply?
Yes, Kelly Davison has studied treatments such as Brentuximab Vedotin, Pembrolizumab, Brentuximab vedotin.
What is the best way to schedule an appointment with Kelly Davison?
Apply for one of the trials that Kelly Davison is conducting.
What is the office address of Kelly Davison?
The office of Kelly Davison is located at: The Research Institute of the McGill University, Montreal, Quebec H4A 3J1 Canada. This is the address for their practice at the The Research Institute of the McGill University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.